Shots:

• Co-Diagnostics’ JV CoSara has received CDSCO’s clearance to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test as an IVD- intended for the qualitative detection of the SARS-CoV-2 virus
• The kit leverages CoPrimer technology & is based on a test originally designed by Co-Diagnostics- who secured CE marking for its Logix Smart SARS-CoV-2 multiplex test in Feb’2020
• To identify the virus presence- both the tests target two gene markers of the SARS-CoV-2 genome i.e. RdRp and E-gene. Additionally- CoSara prior received CDSCO’s approval for RT-PCR tests for mycobacterium tuberculosis- malaria- hepatitis B & C and HPV to be manufactured & sold as IVDs in India

 ­ Ref: Co-Diagnostics | Image: Co-Diagnostics